Moore Capital Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Hold
25,000
0.06% 312
2025
Q4
$1.59M Hold
25,000
0.03% 405
2025
Q3
$1.37M Sell
25,000
-10,000
-29% -$412K 0.03% 391
2025
Q2
$1.16M Hold
35,000
0.02% 364
2025
Q1
$1.41M Hold
35,000
0.05% 293
2024
Q4
$1.65M Hold
35,000
0.03% 339
2024
Q3
$1.85M Hold
35,000
0.05% 309
2024
Q2
$1.9M Hold
35,000
0.04% 273
2024
Q1
$2.45M Buy
35,000
+30,000
+600% +$2.32M 0.05% 251
2023
Q4
$417K Sell
5,000
-20,000
-80% -$724K 0.01% 306
2023
Q3
$737K Hold
25,000
0.02% 316
2023
Q2
$816K Hold
25,000
0.02% 319
2023
Q1
$880K Hold
25,000
0.03% 302
2022
Q4
$1.15M Hold
25,000
0.03% 317
2022
Q3
$1.21M Sell
25,000
-25,000
-50% -$1.2M 0.03% 400
2022
Q2
$1.97M Sell
50,000
-25,000
-33% -$1.01M 0.06% 335
2022
Q1
$2.76M Sell
75,000
-25,000
-25% -$888K 0.09% 314
2021
Q4
$4.56M Buy
+100,000
New +$3.86M 0.12% 243
2020
Q4
Sell
-50,000
Closed -$1.08M 538
2020
Q3
$1.08M Buy
+50,000
New +$1.17M 0.03% 292
2017
Q3
Sell
-50,000
Closed -$605K 233
2017
Q2
$605K Buy
+50,000
New +$695K 0.02% 172

Other funds holding CYTK